GlassScriptPhysician profile
Taylor Allen
NPI 1427647189
$919.54
in general payments reported to CMS, 2019-2025
14 companies · $920 in 2025
The $920 reported for 2025 was more than what 82% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $920.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $920.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $919.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $167.14 | 2025 | Nexplanon |
| Regeneron Healthcare Solutions, INC. | $143.07 | 2025 | Dupixent |
| Sun Pharmaceutical Industries INC. | $140.21 | 2025 | |
| Janssen Biotech, INC. | $114.91 | 2025 | Tremfya |
| Abbvie INC. | $88.65 | 2025 | |
| Novartis Pharmaceuticals Corporation | $69.73 | 2025 | |
| Lilly USA, LLC | $40.08 | 2025 | Taltz, Ebglyss |
| Journey Medical Corporation | $26.51 | 2025 | |
| Mallinckrodt Hospital Products INC. | $24.26 | 2025 | Acthar |
| Leo Pharma INC. | $23.10 | 2025 | Anzupgo |
| Almirall LLC | $22.63 | 2025 | Klisyri |
| Incyte Corporation | $22.59 | 2025 | Opzelura |
| Boehringer Ingelheim Pharmaceuticals, INC. | $19.82 | 2025 | Spevigo |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $16.84 | 2025 | Cabtreo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Taylor Allen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.